Part of the Pharma & Healthcare Insight series of newsletters, Asia Pacific Pharma & Healthcare Insight provides informed and independent analysis on the main trends affecting the pharmaceutical and healthcare industries. Asia Pacific Pharma & Healthcare Insight examines key trends in the market, focusing on individual therapeutic segments and top-line data for prescription drugs, OTCs, generics and the international trade in pharmaceuticals. Regular features include meaningful commentary on the activities of R&D-based multinationals and indigenous players in the fields of drug development, mergers & acquisitions and foreign investment. Asia Pacific Pharma & Healthcare Insight also provides analysis of the impact of regulatory changes on industry performance and competitive intelligence on leading pharmaceutical companies in the region.